Literature DB >> 21167740

Scheie syndrome diagnosed after cerebral infarction.

Daiki Fujii1, Yasuhiro Manabe, Tomotaka Tanaka, Syoichiro Kono, Yasuko Sakai, Hisashi Narai, Nobuhiko Omori, Mahoko Furujyo, Koji Abe.   

Abstract

We report a 41-year-old woman with Scheie syndrome diagnosed after cerebral infarction. She presented with acute onset dysarthria and right upper limb weakness. The neurologic findings revealed dysarthria, right central facial paralysis, mild right hemiparesis, and mild sensory impairment in the right arm and leg. Diffusion-weighted magnetic resonance imaging (MRI) showed subtle high signal lesions in the left corona radiata and posterior limb of the internal capsule. The diagnosis was made by a coarse facial appearance, claw hands, pigmentary degeneration of the bilateral retinas, and a deficiency of the enzymatic activity of lysosomal α-L-iduronidase. The patient was successfully treated with intravenous recombinant tissue plasminogen activator (rtPA) followed by enzyme replacement therapy. The prognosis of this disease would improve with enzyme replacement therapy. It is necessary to be aware of cerebral infarction in patients with Scheie syndrome.
Copyright © 2012 National Stroke Association. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 21167740     DOI: 10.1016/j.jstrokecerebrovasdis.2010.09.006

Source DB:  PubMed          Journal:  J Stroke Cerebrovasc Dis        ISSN: 1052-3057            Impact factor:   2.136


  2 in total

1.  Considering Fabry, but Diagnosing MPS I: Difficulties in the Diagnostic Process.

Authors:  E J Langereis; I E T van den Berg; D J J Halley; B J H M Poorthuis; F M Vaz; J H J Wokke; G E Linthorst
Journal:  JIMD Rep       Date:  2012-10-30

2.  Case Report: Cerebral Revascularization in a Child With Mucopolysaccharidosis Type I.

Authors:  Nathan Grant; J Michael Taylor; Zach Plummer; Kasiani Myers; Thomas Burrow; Lori Luchtman-Jones; Anna Byars; Adrienne Hammill; Katie Wusick; Edward Smith; James Leach; Sudhakar Vadivelu
Journal:  Front Pediatr       Date:  2021-06-10       Impact factor: 3.418

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.